Allianz Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $206M | Sell |
418,106
-108,291
| -21% | -$58.8M | 0.22% | 91 |
|
|
2025
Q4 | $305M | Sell |
526,397
-52,434
| -9% | -$29.7M | 0.31% | 52 |
|
|
2025
Q3 | $281M | Sell |
578,831
-225,286
| -28% | -$105M | 0.31% | 52 |
|
|
2025
Q2 | $326M | Sell |
804,117
-27,688
| -3% | -$11.6M | 0.39% | 39 |
|
|
2025
Q1 | $414M | Buy |
831,805
+38,991
| +5% | +$21.1M | 0.54% | 27 |
|
|
2024
Q4 | $412M | Buy |
792,814
+34,369
| +5% | +$18.9M | 0.55% | 26 |
|
|
2024
Q3 | $469M | Sell |
758,445
-68,186
| -8% | -$40.4M | 0.66% | 25 |
|
|
2024
Q2 | $457M | Sell |
826,631
-71,975
| -8% | -$41.2M | 0.68% | 23 |
|
|
2024
Q1 | $522M | Sell |
898,606
-38,934
| -4% | -$21.8M | 0.81% | 21 |
|
|
2023
Q4 | $498M | Buy |
937,540
+33,360
| +4% | +$16.1M | 0.81% | 20 |
|
|
2023
Q3 | $458M | Buy |
904,180
+83,444
| +10% | +$44.5M | 0.77% | 15 |
|
|
2023
Q2 | $428M | Sell |
820,736
-92,707
| -10% | -$50M | 0.77% | 17 |
|
|
2023
Q1 | $526M | Buy |
913,443
+45,187
| +5% | +$25.5M | 0.93% | 11 |
|
|
2022
Q4 | $478M | Sell |
868,256
-23,716
| -3% | -$12.6M | 0.93% | 11 |
|
|
2022
Q3 | $452M | Sell |
891,972
-556,552
| -38% | -$311M | 0.92% | 11 |
|
|
2022
Q2 | $787M | Sell |
1,448,524
-57,789
| -4% | -$31.8M | 0.75% | 16 |
|
|
2022
Q1 | $890M | Sell |
1,506,313
-6,332
| -0.4% | -$3.64M | 0.66% | 19 |
|
|
2021
Q4 | $1.01B | Buy |
1,512,645
+67,977
| +5% | +$42.4M | 0.69% | 21 |
|
|
2021
Q3 | $825M | Buy |
1,444,668
+36,867
| +3% | +$20.2M | 0.64% | 22 |
|
|
2021
Q2 | $710M | Buy |
1,407,801
+54,685
| +4% | +$25.8M | 0.6% | 34 |
|
|
2021
Q1 | $618M | Buy |
1,353,116
+14,184
| +1% | +$6.77M | 0.6% | 29 |
|
|
2020
Q4 | $624M | Sell |
1,338,932
-245,311
| -15% | -$115M | 0.62% | 31 |
|
|
2020
Q3 | $699M | Buy |
1,584,243
+33,387
| +2% | +$13.8M | 0.81% | 17 |
|
|
2020
Q2 | $562M | Buy |
1,550,856
+27,922
| +2% | +$9.36M | 0.65% | 18 |
|
|
2020
Q1 | $432M | Sell |
1,522,934
-464,892
| -23% | -$147M | 0.58% | 21 |
|
|
2019
Q4 | $646M | Sell |
1,987,826
-48,235
| -2% | -$14.6M | 0.59% | 19 |
|
|
2019
Q3 | $593M | Buy |
2,036,061
+758,469
| +59% | +$217M | 0.58% | 22 |
|
|
2019
Q2 | $375M | Sell |
1,277,592
-8,302
| -0.6% | -$2.29M | 0.35% | 49 |
|
|
2019
Q1 | $352M | Sell |
1,285,894
-4,223
| -0.3% | -$1.05M | 0.35% | 52 |
|
|
2018
Q4 | $289M | Sell |
1,290,117
-228,480
| -15% | -$53.6M | 0.32% | 59 |
|
|
2018
Q3 | $371M | Sell |
1,518,597
-7,465
| -0.5% | -$1.72M | 0.34% | 53 |
|
|
2018
Q2 | $316M | Sell |
1,526,062
-8,026
| -0.5% | -$1.7M | 0.31% | 55 |
|
|
2018
Q1 | $317M | Buy |
1,534,088
+108,799
| +8% | +$22.8M | 0.3% | 58 |
|
|
2017
Q4 | $271M | Buy |
1,425,289
+21,933
| +2% | +$4.2M | 0.21% | 86 |
|
|
2017
Q3 | $266M | Buy |
1,403,356
+146,422
| +12% | +$26.5M | 0.23% | 76 |
|
|
2017
Q2 | $219M | Sell |
1,256,934
-47,156
| -4% | -$7.92M | 0.21% | 87 |
|
|
2017
Q1 | $200M | Sell |
1,304,090
-49,804
| -4% | -$7.61M | 0.2% | 93 |
|
|
2016
Q4 | $191M | Buy |
1,353,894
+486,817
| +56% | +$71.8M | 0.17% | 129 |
|
|
2016
Q3 | $137M | Buy |
867,077
+138,753
| +19% | +$21.4M | 0.13% | 169 |
|
|
2016
Q2 | $108M | Buy |
728,324
+88,301
| +14% | +$13M | 0.11% | 191 |
|
|
2016
Q1 | $90.6M | Buy |
640,023
+8,461
| +1% | +$1.13M | 0.1% | 193 |
|
|
2015
Q4 | $89.8M | Buy |
631,562
+120,532
| +24% | +$16.1M | 0.1% | 206 |
|
|
2015
Q3 | $62.5M | Buy |
511,030
+59,896
| +13% | +$7.8M | 0.07% | 288 |
|
|
2015
Q2 | $58.8M | Sell |
451,134
-108,186
| -19% | -$14.1M | 0.06% | 364 |
|
|
2015
Q1 | $75.1M | Sell |
559,320
-191,891
| -26% | -$24.7M | 0.09% | 262 |
|
|
2014
Q4 | $94.1M | Sell |
751,211
-52,309
| -7% | -$6.36M | 0.1% | 217 |
|
|
2014
Q3 | $97.8M | Buy |
803,520
+92,819
| +13% | +$11.3M | 0.12% | 193 |
|
|
2014
Q2 | $83.9M | Buy |
710,701
+142,926
| +25% | +$16.8M | 0.11% | 238 |
|
|
2014
Q1 | $68.3M | Buy |
567,775
+34,274
| +6% | +$4.07M | 0.08% | 278 |
|
|
2013
Q4 | $59.4M | Buy |
533,501
+36,782
| +7% | +$3.66M | 0.08% | 310 |
|
|
2013
Q3 | $45.8M | Buy |
496,719
+51,202
| +11% | +$4.63M | 0.06% | 353 |
|
|
2013
Q2 | $37.7M | Buy |
+445,517
| New | +$37.1M | 0.05% | 372 |
|
Other funds holding TMO
VCM
Allianz Asset Management's TMO Position: Q1 2026 in Review
Allianz Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $58.8M and leaving 418,106 shares worth $206M. The position accounts for 0.22% of the portfolio, ranked #91.
Allianz Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Allianz Asset Management held 418,106 shares of Thermo Fisher Scientific worth $206M as of Q1 2026.
- Allianz Asset Management sold 108,291 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.8M.
- Thermo Fisher Scientific made up 0.22% of Allianz Asset Management's portfolio in Q1 2026, its #91 holding.
- Allianz Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Thermo Fisher Scientific position peaked at $1.01B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.